Biocon Ltd. | Large-cap | Healthcare
₹350.50
-0.26%
| Biocon Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 150.5B
Gross Profit 98.5B 65.47%
Operating Income 13.3B 8.85%
Net Income 14.3B 9.50%
EPS (Diluted) ₹8.46

Balance Sheet Metrics

Total Assets 588.0B
Total Liabilities 310.8B
Shareholders Equity 277.1B
Debt to Equity 1.12

Cash Flow Metrics

Operating Cash Flow 17.8B
Free Cash Flow 17.2B

Revenue & Profitability Trend

Biocon Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 150.5B 142.0B 109.3B 80.2B 70.1B
Cost of Goods Sold 52.0B 49.1B 36.7B 27.2B 22.5B
Gross Profit 98.5B 92.9B 72.7B 53.0B 47.6B
Operating Expenses 39.0B 38.9B 29.6B 16.8B 18.2B
Operating Income 13.3B 13.5B 12.3B 10.7B 6.0B
Pre-tax Income 18.9B 15.3B 9.0B 9.8B 10.7B
Income Tax 4.6B 2.3B 2.5B 2.1B 2.2B
Net Income 14.3B 13.0B 6.4B 7.7B 8.5B
EPS (Diluted) ₹8.46 ₹8.54 ₹3.87 ₹5.42 ₹6.19

Income Statement Trend

Biocon Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 162.9B 151.8B 123.3B 83.8B 76.0B
Non-Current Assets 425.1B 408.9B 397.1B 120.1B 109.2B
Total Assets 588.0B 560.7B 520.4B 203.9B 185.2B
Liabilities
Current Liabilities 143.3B 153.6B 85.1B 38.3B 42.1B
Non-Current Liabilities 167.5B 154.4B 210.4B 71.0B 58.0B
Total Liabilities 310.8B 308.0B 295.5B 109.2B 100.1B
Equity
Total Shareholders Equity 277.1B 252.7B 224.9B 94.7B 85.1B

Balance Sheet Composition

Biocon Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 14.3B 13.0B 6.4B 7.7B 8.5B
Operating Cash Flow 17.8B -7.5B 43.7B 231.0M 1.9B
Investing Activities
Capital Expenditures -21.4B -16.6B -15.9B -17.0B -15.1B
Investing Cash Flow -1.4B -9.0B -142.7B -14.6B -35.6B
Financing Activities
Dividends Paid -829.0M -2.0B -718.0M - -
Financing Cash Flow -10.8B -14.4B 135.5B 3.6B 26.9B
Free Cash Flow 17.2B 10.2B 1.3B -7.5B -5.9B

Cash Flow Trend

Biocon Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 41.58
Forward P/E 35.50
Price to Book 1.95
Price to Sales 3.08
PEG Ratio 35.50

Profitability Ratios

Profit Margin 6.64%
Operating Margin 15.98%
Return on Equity 5.40%
Return on Assets 1.68%

Financial Health

Current Ratio 1.14
Debt to Equity 66.26
Beta 0.22

Per Share Data

EPS (TTM) ₹8.47
Book Value per Share ₹180.66
Revenue per Share ₹127.45

Financial data is updated regularly. All figures are in the company's reporting currency.